Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debbie L Shawcross

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Journal of Hepatology|September 8, 2025
The barriers to uptake of artificial intelligence in hepatology and how to overcome themJan Clusmann, Maria Balaguer-Montero, Octavi Bassegoda, et al.
Gastroenterology|December 6, 2014
Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitisLee J L Markwick, Antonio Riva, Jennifer M Ryan, et al.
Frontline Gastroenterology|October 26, 2017
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)Mark Hudson, Amr Radwan, Paola Di Maggio, et al.
Journal of Hepatology|November 2, 2023
Corrigendum to "Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis" [J Hepatol 79(4) (2023 Oct) 967-976]Maria Pilar Ballester, Thomas H Tranah, Lorenz Balcar, et al.
The Journal of Infection|May 18, 2025
Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trialBlair Merrick, Désirée Prossomariti, Elizabeth Allen, et al.
The Journal of Infection|August 15, 2025
Erratum to "Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial" [J Infect 91 (2025) 106504]Blair Merrick, Désirée Prossomariti, Elizabeth Allen, et al.
Journal of Hepatology|June 5, 2023
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosisMaria Pilar Ballester, Thomas H Tranah, Lorenz Balcar, et al.
Frontline Gastroenterology|October 20, 2023
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 3: special circumstancesDina Mansour, Steven Masson, John Hammond, et al.
Journal of Hepatology|July 25, 2022
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosisThomas H Tranah, María-Pilar Ballester, Juan Antonio Carbonell-Asins, et al.
Frontline Gastroenterology|October 20, 2023
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 2: decompensated cirrhosisDina Mansour, Steven Masson, Lynsey Corless, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Journal of Hepatology|September 8, 2025
The barriers to uptake of artificial intelligence in hepatology and how to overcome themJan Clusmann, Maria Balaguer-Montero, Octavi Bassegoda, et al.
Gastroenterology|December 6, 2014
Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitisLee J L Markwick, Antonio Riva, Jennifer M Ryan, et al.
Frontline Gastroenterology|October 26, 2017
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)Mark Hudson, Amr Radwan, Paola Di Maggio, et al.
Journal of Hepatology|November 2, 2023
Corrigendum to "Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis" [J Hepatol 79(4) (2023 Oct) 967-976]Maria Pilar Ballester, Thomas H Tranah, Lorenz Balcar, et al.
The Journal of Infection|May 18, 2025
Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trialBlair Merrick, Désirée Prossomariti, Elizabeth Allen, et al.
The Journal of Infection|August 15, 2025
Erratum to "Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial" [J Infect 91 (2025) 106504]Blair Merrick, Désirée Prossomariti, Elizabeth Allen, et al.
Journal of Hepatology|June 5, 2023
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosisMaria Pilar Ballester, Thomas H Tranah, Lorenz Balcar, et al.
Frontline Gastroenterology|October 20, 2023
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 3: special circumstancesDina Mansour, Steven Masson, John Hammond, et al.
Journal of Hepatology|July 25, 2022
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosisThomas H Tranah, María-Pilar Ballester, Juan Antonio Carbonell-Asins, et al.
Frontline Gastroenterology|October 20, 2023
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 2: decompensated cirrhosisDina Mansour, Steven Masson, Lynsey Corless, et al.
Pageof 13